These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34330557)

  • 1. Pertussis immunisation during pregnancy: Antibody levels and the impact of booster vaccine.
    Garlasco J; Bordino V; Marengo N; Rainero E; Scacchi A; Ditommaso S; Giacomuzzi M; Bert F; Zotti CM
    Vaccine; 2021 Aug; 39(35):4957-4963. PubMed ID: 34330557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
    Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
    Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantity and Quality of Antibodies After Acellular Versus Whole-cell Pertussis Vaccines in Infants Born to Mothers Who Received Tetanus, Diphtheria, and Acellular Pertussis Vaccine During Pregnancy: A Randomized Trial.
    Wanlapakorn N; Maertens K; Vongpunsawad S; Puenpa J; Tran TMP; Hens N; Van Damme P; Thiriard A; Raze D; Locht C; Poovorawan Y; Leuridan E
    Clin Infect Dis; 2020 Jun; 71(1):72-80. PubMed ID: 31418814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies.
    Abu-Raya B; Giles ML; Kollmann TR; Sadarangani M
    Front Immunol; 2019; 10():2423. PubMed ID: 31681310
    [No Abstract]   [Full Text] [Related]  

  • 5. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay.
    Fry NK; Litt DJ; Duncan J; Vaghji L; Warrener L; Samuel D; Andrews N; Harnden A; Harrison TG
    J Med Microbiol; 2013 Sep; 62(Pt 9):1281-1289. PubMed ID: 23722435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination.
    Schure RM; Hendrikx LH; de Rond LG; Oztürk K; Sanders EA; Berbers GA; Buisman AM
    Clin Vaccine Immunol; 2013 Sep; 20(9):1388-95. PubMed ID: 23825195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women.
    Sompagdee N; Anuwutnavin S; Phongsamart W; Senawong S; Umrod P; Robkhonburi A
    Vaccine; 2020 Mar; 38(12):2725-2733. PubMed ID: 32070680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-pertussis antibody kinetics following DTaP-IPV booster vaccination in Norwegian children 7-8 years of age.
    Aase A; Herstad TK; Jørgensen SB; Leegaard TM; Berbers G; Steinbakk M; Aaberge I
    Vaccine; 2014 Oct; 32(45):5931-6. PubMed ID: 25218299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
    Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
    J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia.
    Kurova N; Timofeeva EV; Guiso N; Macina D
    Vaccine; 2018 Dec; 36(52):7936-7942. PubMed ID: 30448334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of antibodies specific to diphtheria toxoid, tetanus toxoid, and Haemophilus influenzae type b in healthy children born to Tdap-vaccinated mothers.
    Wanlapakorn N; Maertens K; Thongmee T; Srimuan D; Thatsanathorn T; Van Damme P; Leuridan E; Poovorawan Y
    Vaccine; 2020 Oct; 38(44):6914-6921. PubMed ID: 32888740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve Bordetella pertussis serodiagnosis in recently vaccinated subjects.
    Subissi L; Rodeghiero C; Martini H; Litzroth A; Huygen K; Leroux-Roels G; Piérard D; Desombere I
    Clin Microbiol Infect; 2020 May; 26(5):645.e1-645.e8. PubMed ID: 31610300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pertussis vaccination during pregnancy in Belgium: Follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of age.
    Maertens K; Caboré RN; Huygen K; Vermeiren S; Hens N; Van Damme P; Leuridan E
    Vaccine; 2016 Jun; 34(31):3613-9. PubMed ID: 27142328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of specific antibodies and their influence on cell-mediated immune response in neonatal cord blood after maternal pertussis vaccination during pregnancy.
    Lima L; Molina MDGF; Pereira BS; Nadaf MLA; Nadaf MIV; Takano OA; Carneiro-Sampaio M; Palmeira P
    Vaccine; 2019 May; 37(19):2569-2579. PubMed ID: 30955978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis antibody levels in infants and their mothers receiving combined tetanus-diphtheria toxoid and acellular pertussis vaccine during pregnancy in Turkey.
    Ozdil M; Sonmez C; Tugberk Bakar M; Alici Davutoglu E; Madazli R; Kilic S; Vural M; Perk Y
    Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():212-216. PubMed ID: 34534737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis seroprevalence in mother-infant pairs from India: role of maternal immunisation.
    Viswanathan R; Bafna S; Patil K; Jadhav S; Katendra S; Mishra S; Maheshwari S; Damle H
    Arch Dis Child; 2022 May; 107(5):431-435. PubMed ID: 34526295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A General Lack of IgG Against Pertussis Toxin in Chinese Pregnant Women and Newborns.
    Meng QH; Luo J; Yang F; Shen YJ; Li L; Li LJ; Shi W; Wang YJ; Yao KH
    Pediatr Infect Dis J; 2018 Sep; 37(9):934-938. PubMed ID: 29406469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined tetanus-diphtheria and pertussis vaccine during pregnancy: transfer of maternal pertussis antibodies to the newborn.
    Vilajeliu A; Goncé A; López M; Costa J; Rocamora L; Ríos J; Teixidó I; Bayas JM;
    Vaccine; 2015 Feb; 33(8):1056-62. PubMed ID: 25573035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study.
    Maertens K; Caboré RN; Huygen K; Hens N; Van Damme P; Leuridan E
    Vaccine; 2016 Jan; 34(1):142-50. PubMed ID: 26592142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.